EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Advanced pulmonary carcinoid managed with chemoimmunotherapy and antiangiogenic agent: A case report and literature review

Liqiu Sun, Mengying Liu

Molecular and Clinical Oncology · 24.06.2026 · 25 (2) · 1-6

DOI: 10.3892/mco.2026.2962 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 24.06.2026. Verfasst von Liqiu Sun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tumor Hospital of Mudanjiang, Mudanjiang, Heilongjiang 157009, P.R. China. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

anlotinibcombined systemic therapylobaplatinmediastinal lymph node metastasisneuroendocrine tumorpulmonary carcinoidradiotherapysintilimab

Autor:innen und Institutionen

  • Department of Oncology, Tumor Hospital of Mudanjiang, Mudanjiang, Heilongjiang 157009, P.R. China.

Zitieren

APA

Sun, L., & Liu, M. (2026). Advanced pulmonary carcinoid managed with chemoimmunotherapy and antiangiogenic agent: A case report and literature review. Molecular and Clinical Oncology, 25(2), 1-6. https://doi.org/10.3892/mco.2026.2962

Vancouver

Sun L, Liu M. Advanced pulmonary carcinoid managed with chemoimmunotherapy and antiangiogenic agent: A case report and literature review. Molecular and Clinical Oncology. 2026;25(2):1-6. doi:10.3892/mco.2026.2962

BibTeX
@article{Sun2026,
  author = {Sun, Liqiu and Liu, Mengying},
  title = {Advanced pulmonary carcinoid managed with chemoimmunotherapy and antiangiogenic agent: A case report and literature review},
  journal = {Molecular and Clinical Oncology},
  year = {2026},
  volume = {25},
  number = {2},
  pages = {1--6},
  doi = {10.3892/mco.2026.2962}
}
Kostenlos starten →